UNIVERSITY OF MELBOURNE

GrantConnect (Australian Government grants) · FY 2024 · 2024-07

Smoldering coarse woody debris and air quality Category: Humanities, Arts and Social Sciences (HASS) Research

GrantConnect (Australian Government grants) · FY 2024 · 2024-07

Next generation diamond quantum sensors for future industries Category: Humanities, Arts and Social Sciences (HASS) Research

GrantConnect (Australian Government grants) · FY 2024 · 2024-07

Beneficial flavonoids from eucalypt plantations Category: Humanities, Arts and Social Sciences (HASS) Research

GrantConnect (Australian Government grants) · FY 2024 · 2024-07

Decision support for climate-adapted bushfire risk mitigation Category: Humanities, Arts and Social Sciences (HASS) Research

GrantConnect (Australian Government grants) · FY 2024 · 2024-06

Enabling early psychosis research via anational clinical quality... Category: Health and Medical Research

GrantConnect (Australian Government grants) · FY 2024 · 2024-06

Whose Care is Left Behind? A Multi-Level collective strategy to address... Category: Medical Research

GrantConnect (Australian Government grants) · FY 2024 · 2024-06

Defence research and policy Category: Defence

GrantConnect (Australian Government grants) · FY 2024 · 2024-06

Predicting & Reducing Complications After Surgery with AI: PRECAST4 Category: Health and Medical Research

GrantConnect (Australian Government grants) · FY 2024 · 2024-06

Premature risk meets system failure: understanding, detecting and... Category: Medical Research

GrantConnect (Australian Government grants) · FY 2024 · 2024-06

Treating tiny tummies: Next generation cell therapies for paediatric gut... Category: Medical Research

GrantConnect (Australian Government grants) · FY 2024 · 2024-06

OUTcomes POST COVID - Australian Platform Trial (OUTPOST-APT) Category: Medical Research

GrantConnect (Australian Government grants) · FY 2024 · 2024-06

OUTcomes POST COVID - Australian Platform Trial (OUTPOST-APT) Category: Medical Research

GrantConnect (Australian Government grants) · FY 2024 · 2024-06

Harnessing the next generation of liquid biopsy assays for clinical... Category: Medical Research

GrantConnect (Australian Government grants) · FY 2024 · 2024-05

OMIX3: High-capacity integrated multi-omics Category: Health and Medical Research

GrantConnect (Australian Government grants) · FY 2024 · 2024-03

PhD application Category: Medical Research

GrantConnect (Australian Government grants) · FY 2024 · 2024-03

PhD application Category: Medical Research

GrantConnect (Australian Government grants) · FY 2024 · 2024-03

Theranostic Opportunities for Metastatic Castration-Sensitive Prostate... Category: Medical Research

GrantConnect (Australian Government grants) · FY 2024 · 2024-03

PLATIPUS: A Platform for Adaptive Trials in Perinatal Units Category: Health and Medical Research

GrantConnect (Australian Government grants) · FY 2024 · 2024-03

A novel non-surgical intervention to improve outcomes after anterior... Category: Health and Medical Research

GrantConnect (Australian Government grants) · FY 2024 · 2024-03

Promoting Safer Families: Strengthening primary care to sustainably... Category: Medical Research

GrantConnect (Australian Government grants) · FY 2024 · 2024-03

Promoting Safer Families: Strengthening primary care to sustainably... Category: Medical Research

GrantConnect (Australian Government grants) · FY 2024 · 2024-02

Cirrhotic Cardiomyopathy and Improving Cardiovascular Risk Prediction in... Category: Medical Research

GrantConnect (Australian Government grants) · FY 2024 · 2024-02

Delivering personalised, adaptive deep brain stimulation for Parkinson’s... Category: Medical Research

ARC National Competitive Grants · FY 2024 · 2024-01

The molecular basis of T cell receptor cross-reactivity between MHC and MR1. This project aims to investigate how newly discovered immune cells, known as 'MR1T' cells, function in the body. Preliminary evidence shows that MR1T cells can kill stressed cells. This project expects to generate new knowledge describing precisely how MR1T cells target and kill stressed cells. Expected outcomes of this project include to refine research techniques and models, foster interinstitutional collaborations, and further develop our theory on MR1T cell function. This project should provide significant benefits, such as publication of research articles in high impact journals and generation of experimental tools sought after by researchers in the field. Field of research: 3204 - Immunology Immune cells are critical to the ability of animals and humans to fight infection and disease. This project focuses on a newly discovered type of immune cell that kill stressed cells that no longer function properly. It is not understood how these immune cells target and kill stressed cells and if they can get confused and inappropriately kill healthy cells. It is vital to understand how immune cells are regulated to prevent unnecessary damage. We seek to describe how these immune cells function in mice and humans by examining them in blood and tissue samples using innovative and interdisciplinary research techniques. We expect the knowledge and expertise gained from this project to be published in high impact open access journals and to be of interest to the wider community, accessible through engagements with media, social media and public lectures. The outcomes of the project may lead to long-term commercial interest for the development of immunotherapies, particularly to skin cancers, which are most common among Australians.

ARC National Competitive Grants · FY 2024 · 2024-01

Understanding multiday cycles underpinning human physiology. We recently discovered long-term rhythms modulating activities of our brains and hearts ranging in duration from 3-60 days. The cause of these longer, ‘multiday cycles’ remain unknown. This project aims to understand; causes of multiday cycles (measuring the nervous and autonomic nervous system), their effects (on cognition, sleep, and stress), and quantify the relationship between coupled cyclical systems. The research outcomes can provide fundamental new knowledge about cyclic dynamics governing human physiology, leading to improved rigour in life sciences research. Commercial outcomes include technology to optimise individual productivity, learning, health, and wellbeing based on physiological cycles, with diverse benefits to society. Field of research: 3209 - Neurosciences Our bodies have natural cycles, such as circadian (24-hour) rhythms, which affect a range of human functions. We recently discovered another cycle modulating activities of our brains and hearts ranging in duration from 3-60 days. The cause of these longer, ‘multiday cycles’ remain unknown. Up until recently measuring multiday cycles was too challenging due to long timescales and complex interactions between the brain, heart and stress hormones. Our breakthrough discovery of a rhythmic biomarker in humans, however, will now allow continuous tracking of multiday cycles. This project will track unique multiday cycles while monitoring the brain, heart, sleep and stress response in healthy adults to understand these long rhythms for the first time. New knowledge will be widely disseminated through scientific and industry stakeholders. In collaboration with our corporate partner, Seer Medical, (and research agreement with Fitbit/Google) we will use our proven commercial translation of multiday cycles to develop new lifestyle and workplace products, providing commercial benefits. Understanding multiday cycles will inform time constructs underpinning society, such as the 7-day week, providing social and cultural benefits. As multiday cycles can be used to optimize performance of workers, the project has economic benefits in high-risk industries where managing concentration or fatigue are critical - construction, transport, healthcare.